Biodesix, Inc. reaffirmed revenue guidance for the year 2023. For the year, the company expects total revenue to be between $52 million to $55 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.495 USD | -1.64% | -3.55% | -18.75% |
May. 13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
May. 08 | Transcript : Biodesix, Inc., Q1 2024 Earnings Call, May 08, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.75% | 170M | |
-16.80% | 8.79B | |
+63.16% | 4.19B | |
-4.03% | 2.48B | |
-43.01% | 2.29B | |
-4.82% | 1.97B | |
-18.74% | 1.56B | |
-40.24% | 1.22B | |
+9.42% | 1.13B | |
+18.74% | 933M |
- Stock Market
- Equities
- BDSX Stock
- News Biodesix, Inc.
- Biodesix, Inc. Reaffirms Revenue Guidance for the Year 2023